Lantern Pharma(US:LTRN) Businesswire·2026-03-27 23:23Core Viewpoint - Lantern Pharma confirms that Panna Sharma remains the President and CEO, refuting false claims made by an unverified third-party report [2][4]. Company Leadership - Panna Sharma continues to serve as President, CEO, and Director, actively leading the company's strategy and operations [3]. - The Board of Directors has not approved any changes to the CEO position, affirming their confidence in Sharma's leadership [5]. Response to Misinformation - The company is investigating the origin of the false report and is considering legal actions against those responsible for disseminating misleading information [6]. - Lantern urges investors to rely on official communications and warns against potential stock price manipulation through false information [5]. Upcoming Events - Lantern will host a webcast on March 30, 2026, to discuss the fourth quarter and fiscal year 2025 operating and financial results, led by Panna Sharma [7][11].